Pharsight

Drugs that contain Azelaic Acid

1. Finacea patents expiration

FINACEA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8900554 LEO PHARMA AS Foamable composition and uses thereof
Oct, 2023

(4 months ago)

US10322085 LEO PHARMA AS Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
Oct, 2023

(4 months ago)

US8722021 LEO PHARMA AS Foamable carriers
Oct, 2023

(4 months ago)

US8435498 LEO PHARMA AS Penetrating pharmaceutical foam
Mar, 2024

(5 hours ago)

US7700076 LEO PHARMA AS Penetrating pharmaceutical foam
Sep, 2027

(3 years from now)

US10117812 LEO PHARMA AS Foamable composition combining a polar solvent and a hydrophobic carrier
Oct, 2027

(3 years from now)

US9265725 LEO PHARMA AS Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
Dec, 2027

(3 years from now)

US9211259 LEO PHARMA AS Antibiotic kit and composition and uses thereof
Feb, 2029

(4 years from now)

Market Authorisation Date: 29 July, 2015

Treatment: Topical treatment of inflammatory papules and pustules of mild to moderate rosacea

Dosage: AEROSOL, FOAM;TOPICAL

How can I launch a generic of FINACEA before it's drug patent expiration?
More Information on Dosage

FINACEA family patents

Family Patents